Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	108960
Country	China

Received	2025-04-28 01:59
Peer-Review Started	2025-04-28 01:59
To Make the First Decision
Return for Revision	2025-05-15 12:16
Revised	2025-06-16 14:33
Second Decision	2025-08-07 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-08-07 06:50
Articles in Press	2025-08-07 06:50
Publication Fee Transferred	2025-06-22 16:35
Edit the Manuscript by Language Editor
Typeset the Manuscript	2025-08-25 02:57
Publish the Manuscript Online	2025-09-15 08:38

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-co
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Case Report
Article Title	Rapid cholestasis improvement as key strategy for steroid-refractory immune-related cholangitis: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Zhao Gao, Ji-Xin Zhang, Xiao-Dong Tian, Shi-Kai Wu and Xuan Jin
ORCID	Author(s) ORCID Number Zhao Gao http://orcid.org/0009-0007-6128-4042 Shi-Kai Wu http://orcid.org/0009-0003-9525-4870 Xuan Jin http://orcid.org/0000-0002-9665-5356
Funding Agency and Grant Number
Corresponding Author	Xuan Jin, Chief Physician, PhD, Department of Medical Oncology, Peking University First Hospital, No. 8 Xishiku Street, Beijing 100034, China. 27051079@qq.com
Key Words	Local stent implantation; Steroid-refractory immune-related cholangitis; Immune-related adverse events; Immunotherapy; Case report
Core Tip	Steroid-refractory immune-related cholangitis, characterized by biliary obstruction, can be caused by drugs such as immune checkpoint inhibitors (ICIs). While there a few reports of sclerosing cholangitis after ICI administration, the therapeutic importance of local relief of obstruction has not been reported. Stent implantation provides rapid relief from cholestasis and is an effective approach to the treatment of immune-related cholangitis.
Publish Date	2025-09-15 08:38
Citation	<p>Gao Z, Zhang JX, Tian XD, Wu SK, Jin X. Rapid cholestasis improvement as key strategy for steroid-refractory immune-related cholangitis: A case report. <i>World J Gastrointest Oncol</i> 2025; 17(9): 108960</p>
URL	https://www.wjgnet.com/1948-5204/full/v17/i9/108960.htm
DOI	https://dx.doi.org/10.4251/wjgo.v17.i9.108960

Full Article (PDF)	WJGO-17-108960-with-cover.pdf
CARE Checklist–2016	108960-CARE-Checklist-2016.pdf
Manuscript File	108960_Auto_Edited_062924.docx
Answering Reviewers	108960-answering-reviewers.pdf
Audio Core Tip	108960-audio.m4a
Conflict-of-Interest Disclosure Form	108960-conflict-of-interest-statement.pdf
Copyright License Agreement	108960-copyright-assignment.pdf
Signed Consent for Treatment Form(s) or Document(s)	108960-informed-consent-statement.pdf
Non-Native Speakers of English Editing Certificate	108960-non-native-speakers.pdf
Peer-review Report	108960-peer-reviews.pdf
Scientific Misconduct Check	108960-scientific-misconduct-check.png
Scientific Editor Work List	108960-scientific-editor-work-list.pdf
CrossCheck Report	108960-crosscheck-report.pdf